Show simple item record

ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin

dc.contributor.authorTanaka, Ien_US
dc.contributor.authorChakraborty, Aen_US
dc.contributor.authorSaulnier, Oen_US
dc.contributor.authorBenoit-Pilven, Cen_US
dc.contributor.authorVacher, Sen_US
dc.contributor.authorLabiod, Den_US
dc.contributor.authorLam, EW-Fen_US
dc.contributor.authorBieche, Ien_US
dc.contributor.authorDelattre, Oen_US
dc.contributor.authorPouzoulet, Fen_US
dc.contributor.authorAuboeuf, Den_US
dc.contributor.authorVagner, Sen_US
dc.contributor.authorDutertre, Men_US
dc.date.accessioned2022-04-05T14:16:34Z
dc.date.available2019-12-17en_US
dc.date.issued2020en_US
dc.identifier.issn0305-1048en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/77750
dc.format.extent2676 - 2693en_US
dc.relation.ispartofNUCLEIC ACIDS RESEARCHen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicinen_US
dc.typeArticle
dc.identifier.doi10.1093/nar/gkz1213en_US
pubs.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000525957100040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue5en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume48en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States